CVS Health is set to announce its Q4 earnings, with analysts expecting revenue growth of 6.1% year-on-year to $103.7 billion and adjusted earnings of $1.00 per share. The company beat revenue expectations last quarter, and analysts have reconfirmed their estimates. CVS Health’s stock has underperformed recently, down 2.8% over the last month, despite a positive analyst price target of $94.76.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
CVS Health (CVS) Q4 Earnings: What To Expect
CVS Health is set to announce its Q4 earnings, with analysts expecting revenue growth of 6.1% year-on-year to $103.7 billion and adjusted earnings of $1.00 per share. The company beat revenue expectations last quarter, and analysts have reconfirmed their estimates. CVS Health’s stock has underperformed recently, down 2.8% over the last month, despite a positive analyst price target of $94.76.